Structural mechanisms of protein for biomedical and biotechnological application: pathological processes, targeted therapies, and enzyme des

2026-07-16T07:45:41Z https://icatplus.esrf.fr/oaipmh/request

oai:icatplus.esrf.fr:inv/2391275231 2026-06-20T06:00:12.978Z

4.2 EI 10.15151/ESRF-ES-2391275231 Mari Carmen SALINAS-GARCIA Mari Carmen Salinas-Garcia 0000-0001-9730-3590 Mari Carmen SALINAS-GARCIA Mari Carmen Salinas-Garcia 0000-0001-9730-3590 SERGIO MARTINEZ-RODRIGUEZ Sergio Martinez-Rodriguez 0000-0001-6675-1550 Jose A. GAVIRA GALLARDO Jose A. Gavira Gallardo 0000-0002-7386-6484 SERGIO MARTINEZ-RODRIGUEZ Sergio Martinez-Rodriguez 0000-0001-6675-1550 HASAN DAWI Hasan Dawi 0009-0007-2664-1825 Jose A. GAVIRA GALLARDO Jose A. Gavira Gallardo 0000-0002-7386-6484 Clara MARCO Clara Marco Structural mechanisms of protein for biomedical and biotechnological application: pathological processes, targeted therapies, and enzyme des Example Institute 2029 Data from large facility measurement 2026-06-19T07:30:00Z/2026-06-20T06:00:00Z 2026-06-20T06:00:00Z I CC-BY-4.0 We request the continuation of previous BAG MX-2650, created from the ESRF recommendation to merge several groups from south-east Spain. The team is intrinsically heterogeneous reflected in a diversity of research lines, focused on deciphering the molecular mechanisms of proteins and complexes involved in pathological processes, targeted therapies, and enzyme design, with applications in drug discovery and protein engineering. We are still on the process of a proper organization of shifts awarded, trying to use the provided synchrotron resources in the most efficient way by the different groups. This resource is of paramount relevance to advance our studies as confirmed by the contribution of our experiments in high-impact structural research.